Suppr超能文献

内皮素-1对大鼠离体心脏的影响。

Effects of endothelin-1 on the rat isolated heart.

作者信息

Baydoun A R, Peers S H, Cirino G, Woodward B

机构信息

Pharmacology Group, University of Bath, England.

出版信息

J Cardiovasc Pharmacol. 1989;13 Suppl 5:S193-6. doi: 10.1097/00005344-198900135-00054.

Abstract

This study shows that bolus injections of endothelin-1 (ET-1) (1-30 pmol) produce transient vasodilator and prolonged coronary vasoconstrictor actions. The initial effect on cardiac contractility was a positive inotropic action, but with repeated doses a negative inotropic action developed. Verapamil (0.1 microM) antagonized the vasoconstrictor action of Bay K 8644 but did not affect ET-1-induced vasoconstriction. In contrast, removal of extracellular calcium did block the vasoconstrictor action of ET-1. This suggests that vasoconstriction is due to activation of receptor-rather than potential-operated calcium channels. The ET-1-induced vasoconstriction was not due to the release of platelet-activating factor (PAF) or thromboxane A2 since it was not inhibited by WEB 2086 (0.5 microM), fluribiprofen (2 microM), or BW755C (7 microM). In addition, thromboxane B2 could not be detected in the effluent from the heart. The vasoconstrictor action of ET-1 was potentiated by passage of air through the coronary vascular bed, suggesting that an intact endothelium normally opposes this vasoconstrictor effect.

摘要

本研究表明,大剂量注射内皮素-1(ET-1)(1 - 30皮摩尔)会产生短暂的血管舒张作用和持久的冠状动脉收缩作用。对心脏收缩力的初始作用是正性肌力作用,但重复给药后会出现负性肌力作用。维拉帕米(0.1微摩尔)拮抗了Bay K 8644的血管收缩作用,但不影响ET-1诱导的血管收缩。相反,去除细胞外钙确实会阻断ET-1的血管收缩作用。这表明血管收缩是由于受体激活而非电压门控钙通道激活所致。ET-1诱导的血管收缩并非由于血小板活化因子(PAF)或血栓素A2的释放,因为它不受WEB 2086(0.5微摩尔)、氟比洛芬(2微摩尔)或BW755C(7微摩尔)的抑制。此外,在心脏流出液中未检测到血栓素B2。空气通过冠状动脉血管床会增强ET-1的血管收缩作用,这表明完整的内皮通常会对抗这种血管收缩作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验